Related references
Note: Only part of the references are listed.Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry
Constantinos Ergatoudes et al.
CLINICAL RESEARCH IN CARDIOLOGY (2019)
Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective internationalmulti-ethnic cohort study
Carolyn S. P. Lam et al.
EUROPEAN HEART JOURNAL (2018)
Prevalence and prognostic impact of non-cardiac co-morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community-based study
Annamaria Iorio et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
QRS duration is associated with outcome in symptomatic HF patients. What about ACCF/AHA stages A and B? Data from the DAVID-Berg study
A. Andrea Pozzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2018)
Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis
Josephine Lauritsen et al.
ESC HEART FAILURE (2018)
Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction
Ashish Rastogi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
Ovidiu Chioncel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction
Ida Lofman et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
A comprehensive population-based characterization of heart failure with mid-range ejection fraction
Angela S. Koh et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Prognostic factors in the heart failure with reduced ejection fraction
Mehmet Eyuboglu
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Clinical correlates and prognostic impact of impaired iron storage versus impaired iron transport in an international cohort of 1821 patients with chronic heart failure
Pedro Moliner et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Modes of death in patients with heart failure and preserved ejection fraction
Stefan Aschauer et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)
Mode of Death in Heart Failure With Preserved Ejection Fraction
Muthiah Vaduganathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
Nuria Farre et al.
BMJ OPEN (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Piotr Ponikowski et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Sherif F. Nagueh et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2016)
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Societa Italiana di Biochimica Clinica (SIBIOC)
Antonio Fortunato et al.
CLINICA CHIMICA ACTA (2015)
Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging
Patrizio Lancellotti et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2013)
Relationship between plasma concentrations of N-terminal pro brain natriuretic peptide and the characteristics and outcome of patients with a clinical diagnosis of diastolic heart failure: a report from the PEP-CHF study
John G. F. Cleland et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Impact of Noncardiac Comorbidities on Morbidity and Mortality in a Predominantly Male Population With Heart Failure and Preserved Versus Reduced Ejection Fraction
Sameer Ather et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Systematic Assessment of Causes of Death After Heart Failure Onset in the Community Impact of Age at Death, Time Period, and Left Ventricular Systolic Dysfunction
Douglas S. Lee et al.
CIRCULATION-HEART FAILURE (2011)
Prognostic Value of Baseline Plasma Amino-Terminal Pro-Brain Natriuretic Peptide and Its Interactions With Irbesartan Treatment Effects in Patients With Heart Failure and Preserved Ejection Fraction Findings From the I-PRESERVE Trial
Inder S. Anand et al.
CIRCULATION-HEART FAILURE (2011)
Mortality and Cause of Death in Patients With Heart Failure: Findings at a Specialist Multidisciplinary Heart Failure Unit
Ferran Pons et al.
REVISTA ESPANOLA DE CARDIOLOGIA (2010)
Relation of Disease Pathogenesis and Risk Factors to Heart Failure With Preserved or Reduced Ejection Fraction Insights From the Framingham Heart Study of the National Heart, Lung, and Blood Institute
Douglas S. Lee et al.
CIRCULATION (2009)
Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography
Sherif F. Nagueh et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2009)
Death in Heart Failure A Community Perspective
Danielle M. Henkel et al.
CIRCULATION-HEART FAILURE (2008)
Clinical relevance of non-cardiac determinants of natriuretic peptide levels
Claudio Passino et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2008)
Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)
Serge Masson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure - A report from the OPTIMIZE-HF registry
Gregg C. Fonarow et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES)
F. D. Richard Hobbs et al.
EUROPEAN HEART JOURNAL (2007)
Systolic and diastolic heart failure in the community
Francesca Bursi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Outcome of heart failure with preserved ejection fraction in a population-based study
R. Sacha Bhatia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
SD Solomon et al.
CIRCULATION (2005)
Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure
M Emdin et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Direct renin assay and plasma renin activity assay compared
D Hartman et al.
CLINICAL CHEMISTRY (2004)
Share Paper
